Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma
Egyptian Journal of Cell and Tissue Research · 2025
DOI: 10.21608/ejctr.2024.307403.1021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Egyptian Journal of Cell and Tissue Research, 2025. Verfasst von Abla Sayed Mahmoud und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Basal cell carcinoma and Cutaneous squamous cell carcinoma are the most common malignancies in humans. Five-year survival rates of these tumors are considerably high, and classical treatment methods, such as surgery and radiotherapy, are generally sufficient. However, additional systemic treatment may be required for high-risk, locally advanced, and metastatic BCC and CSCC. PD-L1 activation plays an important role in the tumor’s avoidance of immune surveillance. PD-L1 expression has been studied in different tumor types. However, data on PD-L1 expression in BCC and CSCC are limited. The aim of this study is to evaluate the immunohistochemical expression of PD-L1 in CSCC and BCC cases and detect its relationship with other clinicopathological parameters as a prognostic factor. A total of 47 formalin fixed paraffin embedded skin biopsies of patients with CSCC (19) and BCC (28) were collected and studied immunohistochemically for PD-L1. All biopsies were scored for the PD-L1 expression in tumor cells and TILs. PD-L1expression was positive in 14 (73.7%) of the included CSCC cases, while 5 (26.3%) were negative. Score 0 was seen in 5 cases (26.3%), Score +1 was seen in 6 cases (31.6%), score +2 was seen in 8 cases (42.1%). PD-L1 score in tumor cells showing significant correlation with tumor size, PD-L1 expression in TILs and PD-L1 scores in TILs. According to 28 BCC cases, 27 (96.4%) showed negative PD-L1 expression in tumor cells while only one case (3.6%) has positive expression, however according to PD-L1 expression in TILs 11(39.3%) cases were negative but 17(60.7%) cases showed positive expression.
Zitieren
APA
Mahmoud, A. S., El-Moeze, N. A. A., Alzeem, M. R. A., & Elmaogod, E. A. A. (2025). Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma. Egyptian Journal of Cell and Tissue Research. https://doi.org/10.21608/ejctr.2024.307403.1021
Vancouver
Mahmoud AS, El-Moeze NAA, Alzeem MRA, Elmaogod EAA. Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma. Egyptian Journal of Cell and Tissue Research. 2025. doi:10.21608/ejctr.2024.307403.1021
BibTeX
@article{Mahmoud2025,
author = {Mahmoud, Abla Sayed and El-Moeze, Nadia Ahmed Abd and Alzeem, Mai Rowaey Abd and Elmaogod, Eman Ahmed Abd},
title = {Evaluation of Histopathological and Prognostic Significance of Programmed Death Ligand 1 (PD-L1) Expression of Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma},
journal = {Egyptian Journal of Cell and Tissue Research},
year = {2025},
doi = {10.21608/ejctr.2024.307403.1021}
}
EUVIMED